<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
		>
<channel>
	<title>Comments on: More On Cost-sharing And Medication Compliance</title>
	<atom:link href="http://alignmap.com/2007/07/11/more-on-healthcare-cost-sharing-and-medication-compliance/feed/" rel="self" type="application/rss+xml" />
	<link>http://alignmap.com/2007/07/11/more-on-healthcare-cost-sharing-and-medication-compliance/</link>
	<description>Beyond Compliance, Adherence, &#38; Concordance - Supporting The Patient's Implementation Of Optimal Treatment</description>
	<lastBuildDate>Tue, 08 Sep 2009 01:58:51 +0000</lastBuildDate>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.3.1</generator>
	<item>
		<title>By: Greg Scandlen</title>
		<link>http://alignmap.com/2007/07/11/more-on-healthcare-cost-sharing-and-medication-compliance/comment-page-1/#comment-2828</link>
		<dc:creator>Greg Scandlen</dc:creator>
		<pubDate>Thu, 12 Jul 2007 13:09:55 +0000</pubDate>
		<guid isPermaLink="false">http://alignmap.com/2007/07/11/more-on-healthcare-cost-sharing-and-medication-compliance/#comment-2828</guid>
		<description>Thank you for the thoughtful comments. In these days when everything about health care seems to be so polarized, thoughtfulness itself is refreshing.

I would be interested in learning more about your, and other clinician&#039;s, experience with different forms of cost sharing. I am wary of co-payments in part because it is the third-party payer which determines which drugs will be placed in a particular tier and their motives and methods are suspect, imo. I understand their impulse to lower spending, but that can be done with co-insurance without compromising the physician&#039;s judgment about efficacy.

Greg Scandlen</description>
		<content:encoded><![CDATA[<p>Thank you for the thoughtful comments. In these days when everything about health care seems to be so polarized, thoughtfulness itself is refreshing.</p>
<p>I would be interested in learning more about your, and other clinician&#8217;s, experience with different forms of cost sharing. I am wary of co-payments in part because it is the third-party payer which determines which drugs will be placed in a particular tier and their motives and methods are suspect, imo. I understand their impulse to lower spending, but that can be done with co-insurance without compromising the physician&#8217;s judgment about efficacy.</p>
<p>Greg Scandlen</p>
]]></content:encoded>
	</item>
</channel>
</rss>

